Evidence map›Paper›PMID 29361747›Full record

ReviewInternational journal of molecular sciences2018

Hereditary Fibrinogen Aα-Chain Amyloidosis in Asia: Clinical and Molecular Characteristics.

Masahide Yazaki, Tsuneaki Yoshinaga, Yoshiki Sekijima, Fuyuki Kametani, Nobuo Okumura

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Pathogenesis and kidney prognosis of renal amyloidosis.Cellular and molecular life sciences : CMLS · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Masahide YazakiInstitute for Biomedical Sciences, Shinshu University, Matsumoto 390-8621, Japan. mayazaki@shinshu-u.ac.jp.
Tsuneaki YoshinagaDepartment of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto 390-8621, Japan. kiccho828@gmail.com.
Yoshiki SekijimaInstitute for Biomedical Sciences, Shinshu University, Matsumoto 390-8621, Japan. sekijima@shinshu-u.ac.jp.
Fuyuki KametaniTokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan. kametani-fy@igakuken.or.jp.ORCID 0000-0001-9125-7001
Nobuo OkumuraDepartment of Clinical Laboratory Medicine, Shinshu University School of Health Sciences, Matsumoto 390-8621, Japan. nobuoku@shinshu-u.ac.jp.
Shinshu University · JPTokyo Metropolitan Institute of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary fibrinogen Aα-chain amyloidosis (Aα-chain amyloidosis) is a type of autosomal dominant systemic amyloidosis caused by mutations in

Indexed as

Amyloidosis, FamilialAsiaFemaleFibrinogenHumansIntestinal MucosaKidneyMaleMutationOrgan SpecificityFibrinogenfibrinogen Aalphafibrinogen Aα-chain amyloidosishereditary renal amyloidosislaser microdissectionOstertag-type amyloidosisproteomics analysis

Identifiers

PMID29361747
PMCPMC5796263
OpenAlexW2785567508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.